Revenio Group Oyj
Revenio Group Oyj is a Finnish company specializing in comprehensive eye care diagnostic solutions. It operates internationally, providing fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration. The company's product portfolio includes iCare-branded tonometers, fundus imaging devices, perimeters, and software solutions. Revenio is listed on Nasdaq Helsinki and reported a revenue of €109.7 million in 2025.
Fiscal year 2025 · change from previous year
Development 2021–2025
Business
Share of revenueDevices for measuring eye pressure, primarily for glaucoma screening.
Equipment for capturing detailed images of the retina and optic nerve.
Instruments for assessing visual fields and detecting abnormalities.
Diagnostic software for eye care professionals.
Customers
Revenio's primary customers include ophthalmologists, optometrists, and eye care clinics worldwide. These professionals rely on Revenio's diagnostic tools for accurate and efficient eye disease screening and management. The company's products are also used in hospitals and research institutions for advanced eye health diagnostics. Additionally, Revenio serves the veterinary market with specialized tonometers for animal eye care.
Purchase tonometers and imaging devices for glaucoma and retinal diagnostics.
Use diagnostic tools for routine eye exams and disease management.
Implement integrated solutions for comprehensive patient care.
Utilize specialized tonometers for animal eye health.
Strategy
Revenio's strategic priorities focus on enhancing clinical diagnostics through targeted product innovations and optimizing clinical pathways with integrated solutions. The company emphasizes customer-centric operations and sales, alongside continuous development of its workforce and culture. Revenio aims to sustain profitable growth by leveraging structural growth drivers in the eye care industry and maintaining high entry barriers for competitors.
To improve diagnostic accuracy and efficiency.
To streamline clinical pathways and enhance patient care.
To enhance customer satisfaction and loyalty.
Geography
Q4/2025Revenio operates globally, with a significant presence in the USA, which accounts for 48.3% of its revenue. The company also has a strong market in EMEA, LATAM, and Canada, contributing 33.7% of its revenue. The APAC region represents 16.4% of its sales, while Finland accounts for 1.6%. This diverse geographic footprint helps mitigate regional economic fluctuations and supports growth opportunities in emerging markets.
Share of the revenue the company reports by geography.
Risks
Revenio faces several risks, including intense competition, technological advancements by competitors, and the need for successful commercialization of new technologies. The company is also exposed to geopolitical risks, particularly in regions like China, and operational risks related to supply chain disruptions. Additionally, currency fluctuations, especially between the euro and the dollar, can impact financial performance. Cybersecurity threats pose a risk to business continuity and reputation.
- Cybersecurity threatsImpact: CriticalLikelihood: Medium
Potential impact on operations and reputation.
- Technological competitionImpact: HighLikelihood: Medium
Competitors' advancements could impact market position.
- Geopolitical risksImpact: HighLikelihood: Low
Exposure to unstable regions like China.
- Currency fluctuationsImpact: MediumLikelihood: Medium
Impact on revenue due to euro-dollar exchange rate changes.
Accounting
Judgemental itemsAffects reported revenue and financial comparisons.
Impact: high
Crucial for accurate quarterly performance comparisons.
Impact: medium
Risk if commercialization projects do not succeed.
Impact: medium
Similar listed companies
Publicly listed companies with a comparable business focus.
Orion Oyj
ORNBV · Drug Manufacturers - General
Orion is a Finnish pharmaceutical company that operates globally, focusing on the development, manufacturing, and marketing of human and animal medicines, as…
Terveystalo Oyj
TTALO · Medical Care Facilities
Terveystalo is a Finnish healthcare service provider that operates through three main segments: Healthcare Services, Portfolio Businesses, and operations in Sweden.
Pihlajalinna Oyj
PIHLIS · Medical Care Facilities
Pihlajalinna is a Finnish healthcare company that focuses on providing innovative healthcare pathways and fostering an attractive corporate culture within the industry.
RetinalGenix Technologies Inc.
RTGN · Surgical & Medical Instruments & Apparatus
Kreate Group Oyj
KREATE · Engineering & Construction
Kreate Group Oyj is a Finnish infrastructure company specializing in technically demanding projects that require specialized expertise.
RenovoRx, Inc.
RNXT · Surgical & Medical Instruments & Apparatus
Last updated: 24/09/2026